ORIC Pharmaceuticals, Inc.
ORIC
$10.07
$0.222.23%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -23.89% | -30.56% | -26.96% | -28.60% | -19.68% |
| Total Depreciation and Amortization | 12.63% | 10.38% | 7.27% | 4.92% | 7.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 99.59% | 66.18% | 33.38% | 5.48% | -14.92% |
| Change in Net Operating Assets | -405.63% | 146.06% | -59.82% | -107.60% | -81.29% |
| Cash from Operations | -20.56% | -20.75% | -31.48% | -41.87% | -30.49% |
| Capital Expenditure | -58.69% | -79.26% | -39.93% | 4.91% | 51.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 115.46% | 191.92% | 154.81% | 104.20% | -454.81% |
| Cash from Investing | 113.98% | 190.18% | 151.00% | 101.23% | -481.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7.25% | -99.16% | 47.54% | 14.44% | 14.38% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -288.17% | 38.73% | 25.99% | 72.96% | 72.96% |
| Cash from Financing | 6.87% | -99.27% | 47.74% | 14.93% | 14.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 148.34% | -169.51% | 182.94% | 739.15% | -198.58% |